Rexahn Pharmaceuticals Inc (NYSE MKT LLC:RNN)

0.7557
Delayed Data
As of 10:22am ET
 -0.0195 / -2.52%
Today’s Change
0.65
Today|||52-Week Range
1.52
+7.96%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Revenue and IncomeNet Revenues75.0K0.000.000.00
 
 
Depreciation And Amortization50.7K45.1K42.4K37.1K
 
 
 
 
 
 
Operating ExpensesGross Income24.3K-45.1K-42.4K-37.1K
 
 
 
 
 
General Expenses--16.1M6.1M7.9M
 
 
 
 
Other Operating Expenses--0.00431.1K0.00
 
 
Research And Development--12.0M3.4M3.3M
 
 
 
 
Total Operating Expenses--16.1M6.6M8.0M
 
 
 
 
 
Non-Operating ExpensesOperating Income---16.1M-6.6M-8.0M
 
 
 
 
Extraordinary Credit--4.8M663.9K0.00
 
 
 
Extraordinary Charge--0.00-332.1K-1.4M
 
 
 
Other Expenses---101.6K0.00-204.2K
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-14.0M-11.3M-6.2M-9.5M
 
 
 
 
 
Net Income-14.0M-11.3M-6.2M-9.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS78.7M93.0M97.1M128.6M
 
 
 
 
 
Shares To Calculate EPS Diluted78.7M93.0M97.1M128.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.18-$0.12-$0.06-$0.07
 
 
 
 
 
EPS Diluted-$0.18-$0.12-$0.06-$0.07
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account